- Home
- HIND vs KNRX Comparison
HIND vs KNRX Comparison
Compare HIND & KNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HIND | KNRX |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | Singapore |
| Employees | 2 | N/A |
| Industry | | Computer Software: Programming Data Processing |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2M | 14.1M |
| IPO Year | 2016 | 2023 |
Fundamental Metrics
Financial Performance| Metric | HIND | KNRX |
|---|---|---|
| Price | $2.22 | $0.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 7.4K | ★ 4.6M |
| Earning Date | 05-20-2026 | 06-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 64.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $319,714.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 24.43 | N/A |
| 52 Week Low | $1.75 | $0.31 |
| 52 Week High | $9.69 | $3.45 |
Technical Indicators
Market Signals| Indicator | HIND | KNRX |
|---|---|---|
| Relative Strength Index (RSI) | 46.22 | 52.65 |
| Support Level | $1.99 | $0.39 |
| Resistance Level | $2.35 | $0.49 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 46.03 | 36.07 |
Price Performance
Historical ComparisonAbout HIND Vyome Holdings Inc.
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
About KNRX KNOREX LTD. Class A Ordinary Shares
Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. The company's product, Knorex XPOSM, is a self-service enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications.